Area of research
Artificial Intelligence · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Machine Learning and Algorithms, Adversarial Robustness in Machine Learning, Monoclonal and Polyclonal Antibodies Research, and Immunotherapy and Immune Responses.
Adaptive Dosing Trial Simulation Framework to Inform Dose Optimization: Case Study Using Longitudinal PKPD Models With PF-06804103 Phase 1 Data in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive and Low Solid Tumors.
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.
Application of Machine Learning for Predicting Progression-Free and Overall Survival in Patients With Renal Cell Carcinoma.
Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers.
When Does Adaptivity Help for Quantum State Learning?
Dosing of 3 Targeted Agents in Novel Drug Combinations Used at the Precision Medicine Clinic of the University of California San Diego.
2023cited by 4position: contributor
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach.
Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating Mutations.
The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants.
Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single-Dose, Matched Case-Control Study.
Drugs for the Treatment of Zika Virus Infection.
Entanglement is Necessary for Optimal Quantum Property Testing
Pharmacokinetic Models to Characterize the Absorption Phase and the Influence of a Proton Pump Inhibitor on the Overall Exposure of Dacomitinib.
Drugs for the Treatment of Zika Virus Infection
Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus.
Spectral Signatures in Backdoor Attacks
DSpace@MIT (Massachusetts Institute of Technology) 2018cited by 169position: middle
Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy
Byzantine Stochastic Gradient Descent
arXiv (Cornell University) 2018cited by 100position: last
Sever: A Robust Meta-Algorithm for Stochastic Optimization
eScholarship (California Digital Library) 2018cited by 97position: middle
ZipML: Training Linear Models with End-to-End Low Precision, and a Little Bit of Deep Learning
International Conference on Machine Learning 2017cited by 118position: middle
Exact Model Counting of Query Expressions
The SprayList: a scalable relaxed priority queue
Replacing Mark Bits with Randomness in Fibonacci Heaps